OBJECTIVE: Relapse remains a significant concern in bulimia nervosa, with some patients relapsing within months of treatment completion. The purpose of the study was to identify predictors of relapse within the first 6 months following treatment. METHOD: The 116 participants were bingeing and/or vomiting ≥ 8 times per month before day hospital (DH), and had ≤ 2 episodes per month in the last month of DH and the first month after DH. Rapid relapse was defined as ≥ 8 episodes per month for 3 months starting within 6 months. RESULTS: The rate of rapid relapse was 27.6%. Patients who relapsed soon after DH had higher frequencies of bingeing and vomiting before treatment, engaged in less body avoidance before treatment and were more likely to be slow responders to treatment. Weight and shape concerns and body checking were not significant predictors. DISCUSSION: More frequent bulimic symptoms accompanied by less body avoidance may indicate an entrenchment in the illness which in turn augurs a labored and transient response to DH treatment that is difficult to sustain after intensive treatment ends.
OBJECTIVE: Relapse remains a significant concern in bulimia nervosa, with some patients relapsing within months of treatment completion. The purpose of the study was to identify predictors of relapse within the first 6 months following treatment. METHOD: The 116 participants were bingeing and/or vomiting ≥ 8 times per month before day hospital (DH), and had ≤ 2 episodes per month in the last month of DH and the first month after DH. Rapid relapse was defined as ≥ 8 episodes per month for 3 months starting within 6 months. RESULTS: The rate of rapid relapse was 27.6%. Patients who relapsed soon after DH had higher frequencies of bingeing and vomiting before treatment, engaged in less body avoidance before treatment and were more likely to be slow responders to treatment. Weight and shape concerns and body checking were not significant predictors. DISCUSSION: More frequent bulimic symptoms accompanied by less body avoidance may indicate an entrenchment in the illness which in turn augurs a labored and transient response to DH treatment that is difficult to sustain after intensive treatment ends.
Authors: Richard K Babbs; Julia C Kelliher; Julia L Scotellaro; Kimberly P Luttik; Megan K Mulligan; Camron D Bryant Journal: Physiol Behav Date: 2018-09-24
Authors: Sofia Sacchetti; Paul Robinson; Alexandra Bogaardt; Ajay Clare; Catherine Ouellet-Courtois; Patrick Luyten; Anthony Bateman; Peter Fonagy Journal: BMC Psychiatry Date: 2019-05-06 Impact factor: 3.630
Authors: Emily K Presseller; Elizabeth W Lampe; Megan L Michael; Claire Trainor; Stephanie C Fan; Adrienne S Juarascio Journal: Eat Weight Disord Date: 2022-01-04 Impact factor: 3.008